Adverse events occurred in 21 patients ( 11.7 % ) in the placebo group vs 36 ( 20.0 % ) in the colchicine group ( absolute difference , 8.3 % ; 95 % CI ; 0.76 % -15.9 % ; number needed to harm = 12 ) , but discontinuation rates were similar .